Including results for reata investor relations
Search only for reta investor relations
Reata Pharmaceuticals has been acquired by Biogen.
Jul 28, 2023 · Biogen will host an investor call on July 28, 2023, at 9:00 a.m. ET. The conference call will be accessible through the Investors section of ...
Jun 1, 2023 · Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients.
$2.14
Investor Contacts. Company. Narayan Prabhu, CFO Reviva Pharmaceuticals. Phone: 408.501.8881. Email: info.rp@revivapharma.com. Investor Relations. Ben Shamsian
Missing: reta | Show results with:reta
All earnings call transcripts on Reata Pharmaceuticals, Inc. (RETA) stock. Read or listen to the conference call. Download the investor presentation ...
Missing: relations | Show results with:relations
RETA - Reata Pharmaceuticals Inc - Class A Stock - Stock Price ... Investor, Prev Shares, Latest Shares, Δ Shares ... relation to any financial matter you should ...
People also ask
Did Biogen acquire Reata?
Who are the largest shareholders of Reata Pharmaceuticals?
How much did Biogen pay for Reata?
Who owns Reata Pharmaceuticals?
Investor Relations: Vinny Jindal. Vice President, Strategy. (469) 374-8721. ir@reatapharma.com. Media: Matt Middleman, M.D.. LifeSci Public Relations. (646) 627 ...
Sep 27, 2023 · I googled "reta stock" and their investor relations page was the 4th or 5th result. I mean, when this is the first thing you see, with basic ...
Get today's Reata Pharma stock news. We cover the latest Reata Pharma headlines and breaking news impacting Reata Pharma stock performance.
Jun 11, 2020 · Reata Pharmaceuticals, Inc. and Blackstone Life Sciences Announce $350 Million Strategic Investment. 11 June 2020. Financing will advance ...
Missing: relations | Show results with:relations